Quantification of 24 inorganic impurities in vismodegib and idelalisib anticancer drug substances using ICP-MS
- 17 June 2026
- journal article
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 109 (6) , 906-916
Abstract
Background: Metal impurities in pharmaceutical products can originate from various sources, including manufacturing machinery, catalysts used during drug synthesis, and even the container-closure systems. Objective: The objective of the present study is to accurately quantify trace levels of 24 metal impurities in the active pharmaceutical ingredients (APIs) of the anticancer drugs vismodegib and idelalisib using inductively coupled plasma-mass spectrometry. Methods: The diluent used in the analysis consists of a mixture of 3% nitric acid and 1% hydrochloric acid, while argon serves as the carrier gas. Helium is utilized as the collision gas at a flow rate of 4.3 mL/min. The plasma gas flow rate is maintained at 16 L/min, and the spray chamber temperature is controlled at 2°C to ensure optimal stability during analysis. The dwell time for each metal impurity is set to 0.3 s, and the instrument is precisely tuned in helium mode to achieve accurate and interference-free detection of trace metal impurities. Results: No interference was observed from the calibration blanks, confirming the method’s selectivity and accuracy. The sample recoveries were satisfactory, falling within the United States Pharmacopeia (USP) acceptance range of 70–150%. Conclusion: The analytical procedure was performed in accordance with USP and International Council for Harmonisation (ICH) Q3D(R2) guidelines, and all results were found to be within the established acceptance criteria, thereby validating the reliability and compliance of the method. Highlights: To date, no research studies have been reported on the determination of 24 elemental metal impurities in the drug substances vismodegib and idelalisib. Therefore, the present research develops a unified and reliable analytical method for the quantification of these metal impurities in the active pharmaceutical ingredients (APIs) of both drugs, ensuring compliance with regulatory standards and enhancing the overall quality and safety of the pharmaceutical products. Vismodegib, Idelalisib, ICH Q3D(R2), USP, ICPMS, Toxic metal impuritiesKeywords
This publication has 20 references indexed in Scilit:
- Trace and risk level determination procedure for carcinogenic and genotoxic inorganic catalysts and environmental contaminants from the medicinal manufacturing components and packaging materials by using ICP-MSNext Materials, 2025
- Analytical validation of an inductively coupled plasma mass spectrometry method for urinary iodine concentration measurements in TaiwanJournal of the Formosan Medical Association, 2023
- Study of the use of axial viewed inductively coupled plasma atomic emission spectrometry with ultrasonic nebulization for the determination of select elemental impurities in oral drug productsJournal of Pharmaceutical and Biomedical Analysis, 2018
- Determination of As, Cd, Hg and Pb in continuous use drugs and excipients by plasma-based techniques in compliance with the United States Pharmacopeia requirementsSpectrochimica Acta Part B: Atomic Spectroscopy, 2017
- Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP 〈232〉/〈233〉Journal of Pharmaceutical and Biomedical Analysis, 2017
- Potential metal impurities in active pharmaceutical substances and finished medicinal products – A market surveillance studyEuropean Journal of Pharmaceutical Sciences, 2015
- Study and determination of elemental impurities by ICP-MS in active pharmaceutical ingredients using single reaction chamber digestion in compliance with USP requirementsTalanta, 2015
- Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP /Journal of Pharmaceutical and Biomedical Analysis, 2014
- Development and validation of an ICP-OES method for quantitation of elemental impurities in tablets according to coming US pharmacopeia chaptersJournal of Pharmaceutical and Biomedical Analysis, 2013
- Focused microwave-induced combustion for digestion of botanical samples and metals determination by ICP OES and ICP-MSTalanta, 2012